Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Bitcoin Phase E: Final Shakeouts Are Here

Bitcoin Phase E: Final Shakeouts Are Here

CoinomediaCoinomedia2025/11/15 17:42
By:Aurelien SageAurelien Sage

Bitcoin enters Wyckoff Phase E — the final shakeout before smart money returns. Are you prepared for the next move?Final Shakeouts Before the TurnaroundWill You Be Ready This Time?

  • Bitcoin enters Wyckoff Phase E with panic and capitulation.
  • Smart money is reloading as retail investors sell.
  • This stage signals potential for the next bullish cycle.

Bitcoin is currently undergoing what analysts identify as Phase E in the Wyckoff Market Cycle. This phase marks the climax of the markdown process, characterized by fear, capitulation, and widespread selling pressure. Historically, this is when markets experience their most intense declines — not necessarily due to worsening fundamentals, but because investor sentiment hits rock bottom.

In Phase E, we see panic-selling driven by emotional responses rather than logical analysis. It’s the stage where most retail investors throw in the towel, often too late. The irony? This is usually when long-term investors and institutions — often referred to as “smart money” — start buying again.

Final Shakeouts Before the Turnaround

This phase is crucial. The “final shakeout” is designed to flush out the remaining weak hands — those who bought high and can’t endure the emotional weight of seeing their portfolios dip. As these investors exit the market, savvy players step in quietly, accumulating assets at a discount.

This strategy plays out time and time again. It’s not magic — it’s market psychology. Those who recognize this pattern and remain steady often benefit from the subsequent rally. While it’s impossible to call exact bottoms, recognizing the signs of Wyckoff Phase E helps investors better prepare for what’s next.

BITCOIN: PHASE E CONFIRMED

The Wyckoff blueprint played out to perfection.

We are now deep in Phase E where markdown turns to panic, and capitulation shakes out the weak hands.

This is the zone of final shakeouts.

This is where smart money quietly reloads…
While retail… pic.twitter.com/32T9K0nTGf

— Merlijn The Trader (@MerlijnTrader) November 15, 2025

Will You Be Ready This Time?

The question isn’t whether the cycle will repeat — it’s whether you’re positioned to take advantage of it. Historically, after Phase E, the market enters a new accumulation phase, often leading to a fresh bull market. For those who remain level-headed and strategic, this stage can be a rare opportunity.

Now is the time to reassess, stay informed, and resist emotional decisions. Bitcoin Phase E is a test — not of knowledge, but of discipline.

Read Also :

  • Zero Knowledge Proof (ZKP) Raises the Bar With $17M Advance Proof Pods Manufacturing While XRP & ARB Signal Volatility
  • Bitcoin Whale Adds 251 BTC, Total Now Over $400M
  • OKX CEO Offers 10 BTC Bounty to Disprove Wallet Backdoor
  • Bitcoin Phase E: Final Shakeouts Are Here
  • SEC May Fast-Track XRP ETF Approval
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

Solana News Update: Sunrise Seeks to Resolve Solana's Liquidity Splintering through Immediate Listings

- Wormhole Labs launches Sunrise, a Solana-native listing platform enabling instant liquidity for new tokens like MON, addressing DeFi fragmentation. - The platform uses NTT framework to natively onboard cross-chain assets, retaining liquidity within Solana and integrating with DEXs like Orb and Jupiter. - MON's day-one trading demonstrates Sunrise's potential to solidify Solana as a hub for tokenized assets, with TVL rising 32.7% to $11.5B in Q3 2025. - Analysts highlight Sunrise's role in standardizing h

Bitget-RWA2025/11/24 13:46
Solana News Update: Sunrise Seeks to Resolve Solana's Liquidity Splintering through Immediate Listings

India’s Cryptocurrency Conundrum: Can Updated VDA Regulations Safeguard Progress or Hinder Expansion?

- India's VDA regulatory review aims to align crypto rules with global standards, addressing consumer protection gaps and market integrity risks. - Current fragmented regulations, including 30% profit tax and weak custody laws, have driven users to offshore platforms, stifling local innovation. - Proposed reforms include risk-based token classification, licensing for exchanges, and RWA frameworks to balance innovation with systemic risk mitigation. - A balanced approach could attract investment and strengt

Bitget-RWA2025/11/24 13:46
India’s Cryptocurrency Conundrum: Can Updated VDA Regulations Safeguard Progress or Hinder Expansion?

Bitcoin Updates Today: Bearish Pressure Mounts, Yet Optimistic Bulls Anticipate Future Expansion

- Bitcoin's bearish technical indicators reinforce downward pressure despite short-term recovery attempts. - Ethereum and altcoins mirror Bitcoin's weakness, with $2B in crypto liquidations intensifying selling pressure. - Long-term fundamentals project $17.14B crypto market growth by 2033 driven by institutional adoption and regulatory clarity. - Thailand's Bitkub plans $200M Hong Kong IPO amid local market struggles, highlighting regional listing strategy shifts. - Persistent bearish momentum remains, wi

Bitget-RWA2025/11/24 13:46
Bitcoin Updates Today: Bearish Pressure Mounts, Yet Optimistic Bulls Anticipate Future Expansion

Biomarkers Shine, Results Disappoint: Novo's Attempt at Alzheimer's Falls Short

- Novo Nordisk's Alzheimer's trials for semaglutide failed to meet primary endpoints, causing a 9% premarket stock drop to a multi-year low. - The $3.8B trial showed no disease progression slowing despite biomarker improvements, with UBS estimating only 10% success probability beforehand. - Market ripple effects included Eli Lilly's 0.5% decline and Biogen's 2.7% rise, highlighting GLP-1 drug competition in neurodegenerative therapies. - This setback compounds Novo's challenges: 50% YTD stock decline, obes

Bitget-RWA2025/11/24 13:46
Biomarkers Shine, Results Disappoint: Novo's Attempt at Alzheimer's Falls Short